These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 31087233)

  • 41. Model-based dose calculations for COMS eye plaque brachytherapy using an anatomically realistic eye phantom.
    Lesperance M; Inglis-Whalen M; Thomson RM
    Med Phys; 2014 Feb; 41(2):021717. PubMed ID: 24506608
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Delivered dose changes in COMS plaque-based ocular brachytherapy arising from vitrectomy with silicone oil replacement.
    Morrison H; Larocque MP; Menon G; Sloboda RS; Weis E
    Brachytherapy; 2019; 18(5):668-674. PubMed ID: 31272841
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A modern Monte Carlo investigation of the TG-43 dosimetry parameters for an 125I seed already having AAPM consensus data.
    Aryal P; Molloy JA; Rivard MJ
    Med Phys; 2014 Feb; 41(2):021702. PubMed ID: 24506593
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Monte Carlo and thermoluminescence dosimetry of the new IsoSeed model I25.S17 125I interstitial brachytherapy seed.
    Lymperopoulou G; Papagiannis P; Sakelliou L; Karaiskos P; Sandilos P; Przykutta A; Baltas D
    Med Phys; 2005 Nov; 32(11):3313-7. PubMed ID: 16370418
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The use of new GAFCHROMIC EBT film for 125I seed dosimetry in Solid Water phantom.
    Chiu-Tsao ST; Medich D; Munro J
    Med Phys; 2008 Aug; 35(8):3787-99. PubMed ID: 18777938
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Dose verification of eye plaque brachytherapy using spectroscopic dosimetry.
    Jarema T; Cutajar D; Weaver M; Petasecca M; Lerch M; Kejda A; Rosenfeld A
    Australas Phys Eng Sci Med; 2016 Sep; 39(3):627-32. PubMed ID: 27435983
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Solid phantom material for the dosimetry of iodine-125 seed ophthalmic plaques.
    Hermann KP; Alberti W; Tabor P; Pothmann B; Divoux S; Harder D
    Int J Radiat Oncol Biol Phys; 1993 Aug; 26(5):897-901. PubMed ID: 8344860
    [TBL] [Abstract][Full Text] [Related]  

  • 48. I-125 eye-plaque seed economics: To re-use or to not re-use? A single institutional cost savings analysis of re-using I-125 radioactive seeds for eye-Plaque brachytherapy.
    Cappelli L; Emrich J; Komarnicky-Kocher L; Vinogradskiy Y; Mourtada F
    Brachytherapy; 2024; 23(4):463-469. PubMed ID: 38811275
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Experimental measurements and Monte Carlo calculations for (103)Pd dosimetry of the 12 mm COMS eye plaque.
    Saidi P; Sadeghi M; Tenreiro C
    Phys Med; 2013 May; 29(3):286-94. PubMed ID: 22592132
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Multidimensional dosimetry of ¹⁰⁶Ru eye plaques using EBT3 films and its impact on treatment planning.
    Heilemann G; Nesvacil N; Blaickner M; Kostiukhina N; Georg D
    Med Phys; 2015 Oct; 42(10):5798-808. PubMed ID: 26429254
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Monte Carlo calculations of AAPM Task Group Report No. 43 dosimetry parameters for the (125)I I-Seed AgX100 source model.
    Mourtada F; Mikell J; Ibbott G
    Brachytherapy; 2012; 11(3):237-44. PubMed ID: 21816684
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Dosimetry for 131Cs and 125I seeds in solid water phantom using radiochromic EBT film.
    Chiu-Tsao ST; Napoli JJ; Davis SD; Hanley J; Rivard MJ
    Appl Radiat Isot; 2014 Sep; 92():102-14. PubMed ID: 25038559
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Experimental and theoretical dosimetry of a new polymer encapsulated iodine-125 source--SmartSeed: dosimetric impact of fluorescence x rays.
    Abboud F; Hollows M; Scalliet P; Vynckier S
    Med Phys; 2010 May; 37(5):2054-62. PubMed ID: 20527538
    [TBL] [Abstract][Full Text] [Related]  

  • 54. COMS eye plaque brachytherapy dosimetric sensitivity to source photon energy and seed design.
    Gagne NL; Rivard MJ
    Appl Radiat Isot; 2013 Sep; 79():62-6. PubMed ID: 23728350
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Incorporating patient-specific CT-based ophthalmic anatomy in modeling iodine-125 eye plaque brachytherapy dose distributions.
    Tien CJ; Astrahan MA; Kim JM; Materin M; Chen Z; Nath R; Liu W
    Brachytherapy; 2017; 16(5):1057-1064. PubMed ID: 28778599
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Comparison of 16 mm OSU-Nag and COMS eye plaques.
    Zhang H; Davidorf F; Qi Y
    J Appl Clin Med Phys; 2012 May; 13(3):3632. PubMed ID: 22584165
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Dosimetric comparison of circular Eye Physics and Collaborative Ocular Melanoma Study plaques to treat uveal melanoma.
    Dean MK; Studenski MT; Paez-Escamilla MA; Walter SD; Kwon D; Markoe AM; Harbour JW; Samuels SE
    Brachytherapy; 2019; 18(3):404-410. PubMed ID: 30797699
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A comparison of the shielding effectiveness of silicone oil vitreous substitutes when used with Palladium-103 and Iodine-125 eye plaques.
    Yang YM; Chow PE; McCannel TA; Lamb JM
    Med Phys; 2019 Feb; 46(2):1006-1011. PubMed ID: 30554429
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Ocular brachytherapy dosimetry for 103Pd and 125I in the presence of gold nanoparticles: a Monte Carlo study.
    Asadi S; Vaez-Zadeh M; Vahidian M; Marghchouei M; Masoudi SF
    J Appl Clin Med Phys; 2016 May; 17(3):90-99. PubMed ID: 27167265
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Thermoluminescent dosimetry of the Symmetra 125I model I25.S06 interstitial brachytherapy seed.
    Patel NS; Chiu-Tsao ST; Williamson JF; Fan P; Duckworth T; Shasha D; Harrison LB
    Med Phys; 2001 Aug; 28(8):1761-9. PubMed ID: 11548947
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.